Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorThe First Affiliated Hospital of Xinxiang Medical College

About this trial

Commercial decalcified bone scaffolds were combined with autologous bone marrow mesenchymal stem cells to form tissue engineered bone in vitro to explore the effect of this tissue engineered bone in the clinical repair of long tubular bone defects in limbs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: 18-55 years old, gender unrestricted;

Defective nonunion with bone loss exceeding 30% of the bone cross-section and a length of 2-3 cm;

Solitary bone cysts involving more than 50% of the bone cross-section.

Disqualifiers

Combined with local tumors, tuberculosis, infections or other bone-healing affecting lesions;

Systemic diseases affecting bone healing such as osteofibrous dysplasia, osteogenesis imperfecta, bone dystrophic diseases, and metabolic bone disorders;

Moderate-to-severe osteoporosis (BMD: T-score < -2.5);

Severe systemic conditions including systemic malnutrition, systemic infectious diseases, severe cardiopulmonary diseases, coagulation disorders, and major organ failure;

Trial design

Design model

Single group

Treatments tested in this trial

  • tissue-engineered bone

    Device

    Commercial decalcified bone scaffolds were combined with autologous bone marrow mesenchymal stem cells to form tissue engineered bone in vitro

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Tissue engineered bone on bone defectOther 1 intervention

Trial outcomes

Primary outcomes

1

The scores of bone healing

The scores of bone healing are divided into three kinds: nonhealing: 0;delayed healing: 1; normal healing.

Time frame
About 360 days after surgical treatment of bone defect
2

The adverse event incidence using tissue-engineered bone

The adverse event incidence of tissue-engineered bone

Time frame
About 360 days after surgical treatment of bone defect
3

Bone union (bone healing) evaluation through modified lane and sandhu radiological scoring system

Evaluation of the bone regeneration in the area of intervention in comparison to baseline (V1), by means of X-ray and/or CT scan examination, on visits V1, V2 and V3. X-ray scoring systems have been implemented according to the criteria proposed by modified Lane and Sandhu Radiological Scoring System. This scoring system evaluates bone formation and union. To evaluate the bone formation, there is a scale with 5 points, from 0 to 4 (0=No evidence of bone formation-4=Bone formation occupying 100% of defect). To evaluate bone union, there is a scale with 3 points, from 0 to 2 (0=Non-union-2=Radiogrical union)

Time frame
At the end of visits 1, 2, 3 (respectively performed at screening and 7, 90, 360 days after the surgery)

Secondary outcomes

1

The scores of time of weight loading after operation

The scores of time of weight loading after operation are divided into three kinds: longer than six months: 0; longer than three months: 1; less than three months: 2

Time frame
About 360 days after surgical treatment of bone defect
2

The scores of pain

The scores of pain after operation are divided into four kinds: severe: 0; moderate: 1; slight: 2; none: 3.

Time frame
About 360 days after surgical treatment of bone defect

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.